About Vivici
Vivici is a Consumer company based in Delft (Netherlands) founded in 2022. Vivici has raised $48.47 million across 3 funding rounds from investors including dsm-firmenich, dsm-firmenich and Fonterra. Its chief executive, as recorded, is Stephan Van Sint Fiet. Vivici offers products and services including Viviteinâ„¢ BLG for Beverages, Viviteinâ„¢ BLG for Powder, and Viviteinâ„¢ BLG for Bars. Its focus areas include Food and Agriculture Tech, Food Tech, Novel Foods and Food Products.
Company details
Provider of animal-free dairy proteins. It uses a precision fermentation process to develop dairy alternative protein products.
- Headquarters Delft, Netherlands
- SectorsConsumer
- Email••••••••
- Website vivici.com
- Social LinkedIn
- Total Equity Funding$48.47M (USD)
in 3 rounds
- Latest Funding Round$14.47M (USD), Series A
Jun 2026
- Investorsdsm-firmenich
& 5 more
Products & Services of Vivici
Vivici offers a comprehensive portfolio of products and services, including Vivitein™ BLG for Beverages, Vivitein™ BLG for Powder, and Vivitein™ BLG for Bars.
Sustainable protein for ready-to-drink protein beverages.
Protein for ready-to-mix nutritional powders.
Ingredient enhancing protein bars' texture and nutrition.
Funding Insights of Vivici
Vivici has successfully raised a total of $48.47M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $14.47 million completed in June 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $48.47M
- Total Rounds 3
- Last Round Series A — $14.47M
- Investors Count 6
All 3 funding rounds of Vivici with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2026 | $14.47M | Series A | – | – | |
| Feb 2025 | $34M | Series A | – | ABP Pensioenfonds, dsm firmenich | |
| Aug 2023 | Seed | – | – |
6 investors in total: 6 institutional.
Investors in Vivici
Vivici has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include dsm-firmenich, dsm-firmenich and Fonterra.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Infrastructure and venture capital funding is provided in key sectors. | invest-nl.nl | Amsterdam, Netherlands | ||
Pensions for government and education sectors are managed by ABP. | 1922 | abp.nl | Heerlen, Netherlands | |
Innovative solutions in nutrition, health, and beauty are provided by dsm-firmenich. | 1869 | dsm-firmenich.com | Kaiseraugst, Switzerland | |
Dairy products including milk powder, cheese, and butter are produced. | 2001 | fonterra.com | Auckland, New Zealand | |
Health, nutrition, and bioscience solutions are delivered worldwide. | 1902 | dsm.com | Heerlen, Netherlands | |
| commission.europa.eu |
Investor details for Vivici
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Vivici
11 people are tracked at Vivici (6 in leadership, 5 in team).
| Name | Role | Group |
|---|---|---|
Stephan Van Sint Fiet | CEO | Leadership |
Daniel Bisley | Chief Financial Officer | Leadership |
Marcel Wubbolts | Chief Technology Officer | Leadership |
Marcus Hans | Director R&d | Leadership |
Simon Penfold | Chief Commercial Officer | Leadership |
Madison Clarke | Director Of Business Development | Leadership |
Remco Kornet | Senior Research Scientist | Team |
Sjanien Groenenboom | Research Scientist | Team |
Kiran Subbarayadu | Food Technologist | Team |
Linda Kuijpers | Food Technologist | Team |
Silke Rinsma | Technical Sales Associate | Team |
Complete people profiles for Vivici
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Vivici
3 dated milestones of Vivici across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Vivici is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $14.5M.
Web traffic of Vivici
The website of Vivici (vivici.com) receives about 7.7K visits a month.
- Monthly visits7.7K
▲ 16.9% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vivici
Complete news archive for Vivici
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vivici
Vivici was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Vivici is headquartered in Delft, Netherlands. It is registered at Delft, South Holland, Netherlands.
Stephan Van Sint Fiet is the CEO of Vivici, as recorded in our data.
Vivici is a funded company, having raised a total of $48.47M across 3 funding rounds to date.
Provider of animal-free dairy proteins. It uses a precision fermentation process to develop dairy alternative protein products.
Vivici offers Viviteinâ„¢ BLG for Beverages, Viviteinâ„¢ BLG for Powder, and Viviteinâ„¢ BLG for Bars.
Vivici has 6 investors. Key investors include dsm-firmenich, dsm-firmenich, Fonterra, ABP Pensioenfonds, and Invest-NL.